420 Pharma: Start of sales of "420" cannabis brand


Four 20 Pharma launches sales of its own cannabis brand "420

PDF Four 20 Pharma launches cannabis brand

Paderborn, September 2020 - As announced in March, Four 20 Pharma GmbH, manufacturer, wholesaler and importer of medical cannabis and medical devices, will start the delivery of its first own cannabis brand "420 NATURAL" on 21.09.2020. For this purpose, an international supply agreement has been signed with Northern Green Canada Inc ("NGC"). NGC is the first privately owned, EU GMP licensed Canadian producer of cannabis. The shipment from Canada was successfully executed and is the prelude to a larger supply agreement. Currently, the medicinal cannabis is being repackaged into pharmacy dispensary quantities, so that delivery is expected to take place from the end of this week.

The Paderborn-based company has received a corresponding certificate of analysis from Eurofins. Four 20 Pharma GmbH has set itself the goal of meeting the highest standards in order to guarantee patients the greatest possible degree of safety and efficacy. Therefore, the medical cannabis importer had the flowers additionally tested by a second independent German laboratory for purity, THC content and quality in order to be able to confirm the already existing certificate.

"We take our promise of quality very seriously and we have fully succeeded in doing so with the new strain. Therefore, we are sure that our first own cannabis brand "420 NATURAL", which is not subjected to irradiation, will establish itself very quickly on the German market," explains Thomas Schatton, CEO of Four 20 Pharma GmbH. "With a THC range of 20% to 25%, the indica-dominant strain Gorilla Glue forms the basis of our future growing product range. We look forward to continuing to secure and stabilize patient supply with this premium product. Long-term supply contracts with high import volumes guarantee a steady supply."

Lisa McCormack, President and CEO of NGC, is pleased, "This shipment represents an important milestone for our company. We can now support patients in Germany who are facing limited availability of medical cannabis due to lack of supply as a result of the current situation. We are pleased to have Four 20 Pharma as a partner on our side, who has all the prerequisites for a successful market launch in this still young market in Germany."


About Four 20 Pharma GmbH

Four 20 Pharma GmbH is GDP and GMP certified as a manufacturer, wholesaler and importer of medical cannabis as well as medical devices. The company, based in Paderborn, Germany, was founded in 2018 and holds a narcotics license in accordance with Section 3 of the German Narcotics Act (BtMG) and a wholesale drug license in accordance with Section 52a of the German Medicines Act (AMG) for all of Europe. In addition, the medical cannabis specialist holds the necessary import licenses for the importation of medical cannabis into Germany, a manufacturing permit, and the necessary, product-specific permit in accordance with § 7 AMG and § 1 AMRadV for the marketing of medicinal products. Four 20 Pharma GmbH is involved as a Gold Sponsor with the Association for Cannabis as Medicine (ACM) and as a Platinum Sponsor with the International Association for Cannabinoid Medicines (IACM).

The company supports physicians, pharmacies, medical institutions and patients as a reliable partner in all aspects of medical cannabis. For more information, please visit our website at www.420pharma.de.


E-mail: info@420pharma.de

Phone: (+49) 5251 3903210

About Northern Green Canada Inc.

Northern Green Canada Inc. is a federally licensed, EU GMP certified medical cannabis manufacturer focused on providing cannabis medicines for a better quality of life. NGC is a research and development-driven company committed to patient health and wellness. The experienced team of experts operates in an indoor cultivation and processing facility with an area of 2500 sqm2 and an expansion capacity of 4275 sqm2. The company is expanding its extraction capacity to produce oils and is working with respected partners on treatment-based cannabis medicines. For more information, please visit our website at www.northerngreencanada.com.


Email: mmill@northerngreencanada.com

Press Contact:

Four 20 Pharma Ltd.

E-mail: info@420pharma.de

Phone: +49 5251 3903210

Sticky Phone icon